Skip to content
Episode 140 - May 2, 2025 episode artwork

May 8, 2025 58 min

Episode 140 - May 2, 2025

from Biotech Hangout Hosted by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

On this week’s episode, Eric Schmidt and Sam Fazeli are joined by special guests Adam Feuerstein and Peter Kolchinsky to discuss the upward movement of the biotech market along with strong drug launches, deals, and net-positive Q1 earnings, all signaling things may be improving. Next, the group notes the FDA is unlikely to undergo significant reorganization and while this stability is reassuring, complacency should be avoided as headwinds persist. Despite the turmoil, the pharmaceutical industry remains resilient, as people prioritize their health and the need for medicine. The conversation shifts back to the new FDA leadership, highlighting Makary and RFK Jr.’s relationship, anti-vaccine rhetoric and the impacts this may have on vaccine trials. The group notes that at conversations at AACR suggest that large pharma is not worried about the FDA changes, while smaller companies have concerns. BridgeBio’s successful launch of Attruby was also discussed, highlighted as a positive trend for the industry. The conversation shifts back to vaccine uncertainty and the future of mRNA given the skepticism from healthcare professionals, illustrated by Moderna’s potential delays fortheir flu vaccine combo. The episode ends with Adam’s optimistic take on biotech’s recent turn toward stabilization. *This episode aired on May 2, 2025.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Episode 140 - May 2, 2025

0:00 58:45

No transcript yet.

Requests help us decide what to transcribe next.

Talking Biotech with Dr. Kevin Folta Kevin Folta Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050.Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics. State of Digital Clinical Trials Podcast Veeva State of Digital Clinical Trials is a Veeva podcast hosted by Manny Vazquez, Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric? The Biotech Startups Podcast Excedr The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday. Healthcare NOW Radio Podcast Network - Discussions on healthcare including technology, innovation, policy, data security, telehealth and more. Visit HealthcareNOWRadio.com Healthcare NOW Radio and Podcast Network - Radio and Podcasts for the Healthcare Industry RADIO FOR THE HEALTHCARE INDUSTRYHealthcare NOW Radio and Podcast Network offers discussions on the latest developments and trends impacting the industry including: health tech, health IT, healthcare innovation, healthcare policy, healthcare data security, telehealth, interoperability, biotech, med tech, value-based care, pharma, healthcare compliance, and much more. Shows are hosted by industry thought leaders. Guests are a "who's who" across the healthcare spectrum. The listening audience is predominantly physician and hospital-based, and the healthcare industry at large.

Frequently asked questions

How long is this episode of Biotech Hangout?

This episode is 58 minutes long.

When was this Biotech Hangout episode published?

This episode was published on May 8, 2025.

Can I download this Biotech Hangout episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.